deaths (OS)progression or deaths (PFS)RFS/DFS

endometrial cancer endometrial cancer

versus Standard of Care (SoC)
lenvatinib in association vs. Standard of Care (SoC) 1 certainty unassessable-32% certainty unassessablestatistically conclusive-40%-

endometrial cancer - (neo)adjuvant (NA) endometrial cancer - (neo)adjuvant (NA)